• PDF: Delivered by email usually within 12 to 48 UK business hours.

France Quarterly Beverage Tracker Report Q2 2012

  • Publication Date:September 2012
  • Publisher:Canadean
  • Product Type: Report
  • Pages:23

France Quarterly Beverage Tracker Report Q2 2012


Canadean's "Dar Al Dawa Development and Investment Co. Ltd." contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis as well as key employees


This report is a crucial resource for industry executives and anyone looking to access key information about "Dar Al Dawa Development and Investment Co. Ltd."

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.


  • Identifies crucial company information about "Dar Al Dawa Development and Investment Co. Ltd." along with major products and services for business intelligence requirements.
  • Provides analysis on financial ratios.
  • Identifies key employees to assist with key business decisions.
  • Provides annual and interim financial ratios.

Reasons To Buy

  • Enhance your understanding of "Dar Al Dawa Development and Investment Co. Ltd."
  • Increase business/sales activities by understanding customers' businesses better.
  • Recognize potential partnerships and suppliers.
  • Qualify prospective partners, affiliates or suppliers.
  • Acquire up-to-date company information and an understanding of the company's financial health.

Key Highlights

Dar Al Dawa Development and Investment Co. Ltd. (Dar Al Dawa) is into development and manufacture of pharmaceuticals and consumer health care products. The company offers over 200 prescription and over-the-counter medicines. Its products include antibiotics, antihyperglycemics, chemotherapeutics, cardiovascular products, dermatological products, ophthalmology, respiratory products, mouth washes, and vitamin products. The company distributes its products in more than 20 markets, including the Middle East, North and East Africa and Eastern Europe. It was founded in 1975. Dar Al Dawa is headquartered in Amman, Jordan.

  • 1 Business Analysis
    • 1.1 Company Overview
    • 1.2 Major Products and Services
  • 2 Analysis of Key Performance Indicators
    • 2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
    • 2.2 Key Financial Performance Indicators
      • 2.2.1 Revenue and Operating Profit
      • 2.2.2 Asset and Liabilities
      • 2.2.3 Operational Efficiency
      • 2.2.4 Solvency
    • 2.3 Key Competitors
  • 3 Key Employees
  • 4 Appendix
    • 4.1 Methodology
    • 4.2 Ratio Definitions
    • 4.3 Disclaimer
  • List of Tables
    • Table 1: Major Products and Services
    • Table 2: Key Ratios - Annual
    • Table 3: Key Ratios - Interim
    • Table 4: Key Capital Market Indicators
    • Table 5: Key Employees
  • List of Figures
    • Figure 1: Revenue and Operating Profit
    • Figure 2: Financial Position
    • Figure 3: Operational Efficiency
    • Figure 4: Solvency
+44 20 8816 8548

Ask a question about France Quarterly Beverage Tracker Report Q2 2012

Enter the characters you see in the picture below